Italian evidence-based Guidelines for the management of influenza-like syndrome in adults and children

Annali dell'Istituto Superiore di Sanita

Volumn 45, Issue 2, 2009, Pages 185-192

  Morciano, Cristina ^a   Vitale, Arianna ^a   Masi, Salvatore De ^b   Sagliocca, Luciano ^c   Sampaolo, Letizia ^a   Lacorte, Eleonora ^a   Mele, Alfonso ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ASL 6   (Italy)

^c ASL Salernol   (Italy)

Author keywords

Antibiotic; Antiviral; Fu; Grippe; Guidelines; Influenza

Indexed keywords

ADULT; ARTICLE; CHILD; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; INFLUENZA; ITALY;

ADULT; CHILD; EVIDENCE-BASED MEDICINE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; ITALY;

EID: 69249193582     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and Interpretation of rapid influenza tests in children. Pediatrics 2007;119(1): e6-e11.
2. Drinka PJ. Experience with the rapid Direct gen test for influenza. J Am Med Dir Assoc 2006;7(1):37-9.
3. Weitzel T, Schnabel E, Dieckmann S, et al. Evaluation of a new point-of-care test for influenza A and B virus in travellers with influenza-like symptoms. Clin Microbiol Infect 2007;13(7):665-9.
4. Simmerman JM, Chittaganpitch M, Erdman D, et al. Field performance and new uses of rapid influenza testing in Thailand. Int J Infect Dis 2007;11(2):166-71.
5. Smit M, Beynon KA, Murdoch DR, et al. Comparison of the NOW Influenza A and B, NOW Flu A, NOW Flu B, and Directigen Flu A+B asays, and immunofluorescence with viral culture for the detection of influenza A and B viruses. Diagn Microbiol Infect Dis 2007;57(1):67-70.
6. Alexander R, Hurt AC, Lamb D, et al. A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population. Commun Dis Intell 2005;29(3):272-6.
7. Cruz AT, Cazacu AC, McBride LJ, et al. Performance characteristics of a rapid immunochromatographic assay for detection of influenza virus in children during the 2003 to 2004 influenza season. Ann Emerg Med 2006;47(3):250-4.
8. Hurt AC, Alexander R, Hibbert J, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007;39(2):132-5.
9. Jefferson T. Amantadina and Rimantadina for preventing and treating Influenza A in Adults. Cochrane Database Syst Rev 2004; (3): CD001169.
10. Turner D. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003;7(35):1-170.
11. Gravenstein S. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Higly Vaccinated Longterm Care Population. J Am Med Dir Assoc 2005; 6: 359-66. (Pubitemid 41755354)
12. Matheson NJ. Neuraminidase inhibitors for preventing and treating influenza in children (Review). Cochrane Database Syst Rev 2007 Jan 24; (1): CD002744.
13. Jefferson T. Neuraminidase inhibitors for preventing and treating influenza in healthy adults (Review). Cochrane Database Syst Rev 2006;19(3): CD001265.
14. Bettis R. Impact of influenza treatment with Oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents. Clin Drug Invest 2006;26(6):329-40.
15. Del Mar. CB. Antibiotic for sore throat. Cochrane Database Syst Rev 2006; (4): CD000023.
16. Petersen I. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 2007. doi:10.1136/bmj. 39345.405243. BE.
17. Fahey T. Antibiotics for acute bronchitis (Review). Cochrane Database of Systematic Reviews 72004; 4. Art. No.: CD000245. DOI:10.1002/14651858. CD000245.pub2.
18. Spurling GK. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2007; (3): CD004417.
19. Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007;14(5):477-84.
20. Sarrel E. M. Antipyretic treatment in young children with fever. Arch Pediatr Adolesc Med 2006; 160: 197-202.
21. Autret-Leca, Gibb IA, Goulder MA. Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized, blinded study. Curr Med Res Opin 2007;23(9):2205-11.
22. Erlewyn-Lajeunesse S, Coppens K, Hunt LP, et al. Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch Dis Child 2006;91(5):414-6.
23. Prado J, Daza R, Chumbes O, et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: a randomized controlled trial. Sao Paulo Med J 2006;124(3):135-40.
24. Ranghanathan SS, Sathiadas MG, Sumanasena S, et al. Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children. Indian J of Pediatrics 2006;73(10):871-5.
25. Nabulsi MM. Alternating ibuprofen and acetaminophen in the treatment of febrile children: a pilot study. BMC Medicine 2006; 4: 4.
26. Grebe W, Ionescu E, Gold MS, et al. A multicenter, randomized, double-blind, double-dummy, placebo-and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms. Clin Ther 2003;25(2):444-58.
27. Bachert C, Chuchalin AG, Eisebitt R, et al. Aspirin Compared with Acetaminophen in the Treatment of Fever and Other Symptoms of Upper Respiratory Tract Infection in Adults: A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Single-Dose, 6-Hour Dose-Ranging Study. Clin Ther 2005;27(7):993-1003.
28. Laporte JR, Ibáñez L, Vidal X, et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 2004;27(6):411-20.
29. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclooxigenase-2 inhibitors and traditional non-steroidal anti-infammatory increase the risk of atherothrombosis? Meta-analysis of randomised trials drugs. BMJ 2006;332(7553):1302-8.
30. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinfammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(12):1634-42.
31. Vickers AJ, Smith C. Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndrome (Review). Cochrane Database Syst Rev 2006; 3: CD001957.
32. Chen X Y, Wu TX, Liu GJ, et al. Chinese medicinal herbs for influenza (Review). Cochrane Database Syst Rev 2007; (4): CD004559.
33. Challen K, Bright J, Bentley A, et al. Physiological-social score (PMEWS) vs CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy. BMC Health Serv Res 2007; 7: 33.
34. Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalisation due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004;189(3):450-9.
35. Cooksley CD, Avritscher EBC, Bekele BN, et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005;104(3):618-28.
36. Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007;176(4):463-8.
37. MMWR-CDC. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007;56(RR06);1-54.
38. Lim WS. Pandemic Flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007; 62 (Suppl 1): 1-46.
39. Shehab N, Patel PR, Srinivasan A, et al. Emergency Department Visits for Antibiotic-Associated Adverse Events. Clin Infect Dis 2008: 47 (6): 735-43.
40. Mitka M. Emergency departments see high rates of adverse events from antibiotic use. JAMA 2008;300(13):1505-6.